Product Images Doxazosin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Doxazosin NDC 82804-087 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

82804-087-30 - doxazosin 4mg 100

82804-087-30 - doxazosin 4mg 100

This text provides detailed information about a medication named Doxazosin 4mg. Each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin. The tablets are white to off-white, capsule-shaped, scored, imprinted with "APO" on one side and "095" with a partial bisect on the other. The medication is manufactured by Apotex Inc. in Toronto, Canada. It is recommended to store the tablets at 20°-25°C (68°-77°F) and keep them out of the reach of children. The medication is packaged by Proficient Rx LP in Thousand Oaks, CA. Lot numbers and expiration dates are provided.*

doxazosin-structure.jpg - doxazosin structure

doxazosin-structure.jpg - doxazosin structure

figure1.jpg - figure1

figure1.jpg - figure1

This is a statistical comparison showing the mean change in total symptom score from baseline and the mean increase in maximum urinary flow rate (mL/sec) from baseline. The duration of treatment in weeks is also displayed. The results indicate significance compared to placebo and baseline. Doxazosin was titrated up to a maximum dose of 8 mg during the study.*

table3.jpg - table3

table3.jpg - table3

This is a summary of effectiveness data from placebo-controlled trials evaluating the maximum flow rate and symptom scores in patients receiving doxazosin for benign prostatic hyperplasia (BPH). The data includes baseline values and changes in flow rate and symptom scores for different doses of doxazosin compared to placebo. The studies were conducted over different periods, with variations in dose titration. The AUA questionnaire and Modified Boyarsky Questionnaire were used to evaluate symptoms. The results suggest that doxazosin has a positive effect on symptoms and flow rate in patients with BPH.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.